Polycystic ovary syndrome and pregnancy Síndrome de ovario poliquístico y embarazo
Author
dc.contributor.author
Sir Petermann, Teresa
Author
dc.contributor.author
Ladrón de Guevara, Amanda
Author
dc.contributor.author
Villarroel, Ana Claudia
Author
dc.contributor.author
Preisler, Jessica
Author
dc.contributor.author
Echiburú López, Bárbara
Author
dc.contributor.author
Recabarren, Sergio
Admission date
dc.date.accessioned
2019-03-15T16:03:25Z
Available date
dc.date.available
2019-03-15T16:03:25Z
Publication date
dc.date.issued
2012
Cita de ítem
dc.identifier.citation
Revista Medica de Chile, Volumen 140, Issue 7, 2018, Pages 919-925
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.issn
07176163
Identifier
dc.identifier.other
10.4067/S0034-98872012000700015
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165832
Abstract
dc.description.abstract
Polycystic ovary syndrome (PCOS) is a common endocrine metabolic dysfunction closely associated with insulin resistance and obesity, which predisposes to pregnancy complications and prenatal programming of the offspring. The aim of this review is to report our experience in PCOS patients who became pregnant and were followed during the whole pregnancy. Firstly, we analyzed the effect of pregnancy on PCOS pathophysiology and secondly the role of PCOS in pregnancy outcomes. Regarding the first point, during normal pregnancy a progressive insulin resistance, serum lipid changes and an increase in androgen levels is observed, which is exacerbated in the PCOS condition. This adverse intrauterine environment could have a prenatal programming effect with detrimental consequences for female or male fetuses. Regarding the second point, PCOS is associated with an increased risk for maternal complications such as gestational diabetes (GDM) and pregnancy-induced hypertension. Moreover, these adver